Verheugt FWA - Search Results

1

Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD-AF registry.

Seelig J, Hemels MEW, Xhaët O, Bongaerts MCM, de Wolf A, Groenemeijer BE, Heyse A, Hoogslag P, Voet J, Herrman JR, Vervoort G, Hermans W, Wollaert B, Boersma LVA, Hermans K, Lucassen A, Verstraete S, Adriaansen HJ, Mairesse GH, Terpstra WF, Faes D, Pieterse M, Virdone S, Verheugt FWA, Cools F, Ten Cate H; GARFIELD-AF investigators. Seelig J, et al. Among authors: verheugt fwa. J Thromb Haemost. 2020 Dec;18(12):3280-3288. doi: 10.1111/jth.15081. Epub 2020 Sep 25. J Thromb Haemost. 2020. PMID: 32886853 Free PMC article.

2

Anticoagulation after artificial valve replacement with or without atrial fibrillation: how much is really needed?

Verheugt FW. Verheugt FW. Thromb Haemost. 1999 Sep;82 Suppl 1:130-5. Thromb Haemost. 1999. PMID: 10695504 Review.

3

[Therapeutic angiogenesis as a new experimental treatment for vascular disease].

Lucassen AM, de Waal RM, Verheugt FW. Lucassen AM, et al. Ned Tijdschr Geneeskd. 2000 Apr 1;144(14):650-5. Ned Tijdschr Geneeskd. 2000. PMID: 10774292 Review. Dutch.

4

Pretreatment with oral anticoagulants decreases platelet activation in patients before and after percutaneous coronary intervention.

ten Berg JM, Gerritsen WB, Haas FJ, Kelder JC, Verheugt FW, Thijs Plokker HW. ten Berg JM, et al. Thromb Haemost. 2002 Dec;88(6):924-30. Thromb Haemost. 2002. PMID: 12529740 Clinical Trial.

5

Stroke prevention in atrial fibrillation.

Verheugt FW. Verheugt FW. Neth J Med. 2006 Feb;64(2):31-3. Neth J Med. 2006. PMID: 16517985 Free article.

6

Safety of the combination of intensive cholesterol-lowering therapy with oral anticoagulation medication in elderly patients with atrial fibrillation: a randomized, double-blind, placebo-controlled study.

Enajat M, Teerenstra S, van Kuilenburg JT, van Sorge-Greve AH, Albers-Akkers MT, Verheugt FW, Pop GA. Enajat M, et al. Drugs Aging. 2009;26(7):585-93. doi: 10.2165/10558450-000000000-00000. Drugs Aging. 2009. PMID: 19655825 Clinical Trial.

7

The influence of clinical characteristics, laboratory and inflammatory markers on 'high on-treatment platelet reactivity' as measured with different platelet function tests.

Elsenberg EH, van Werkum JW, van de Wal RM, Zomer AC, Bouman HJ, Verheugt FW, Berg JM, Hackeng CM. Elsenberg EH, et al. Thromb Haemost. 2009 Oct;102(4):719-27. doi: 10.1160/TH09-05-0285. Thromb Haemost. 2009. PMID: 19806258

8

Novel oral anticoagulants to prevent stroke in atrial fibrillation.

Verheugt FW. Verheugt FW. Nat Rev Cardiol. 2010 Mar;7(3):149-54. doi: 10.1038/nrcardio.2009.235. Nat Rev Cardiol. 2010. PMID: 20179722 Review.

9

[New antithrombotics for atrial fibrillation].

Verheugt F. Verheugt F. Ned Tijdschr Geneeskd. 2011;155:A2143. Ned Tijdschr Geneeskd. 2011. PMID: 21291575 Review. Dutch.

10

International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).

Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Lip GY, Mantovani LG, Verheugt FW, Jamal W, Misselwitz F, Rushton-Smith S, Turpie AG. Kakkar AK, et al. Am Heart J. 2012 Jan;163(1):13-19.e1. doi: 10.1016/j.ahj.2011.09.011. Epub 2011 Nov 20. Am Heart J. 2012. PMID: 22172431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

620 results

Search Page

Filters